Divergent Response to Growth Hormone in Two Siblings With Cartilage-Hair Hypoplasia: A Case Report
Cartilage-hair hypoplasia (CHH) is a rare autosomal recessive skeletal dysplasia caused by biallelic variants in the RMRP gene. It combines disproportionate short stature with variable immunological, hematological, and gastrointestinal involvement. Evidence on treatment with recombinant human growth hormone (rhGH) in this condition is limited and inconsistent. We describe the case of two siblings with genetically confirmed CHH who presented with severe short stature and subnormal growth hormone stimulation tests and who were treated with rhGH for different periods. The boy showed a clear increase in growth velocity and height standard deviation score, partly maintained after treatment was stopped, whereas the girl showed only a minimal and transient response. Both siblings later developed obesity-related metabolic changes, including insulin resistance, and had T-cell lymphopenia, which was clinically more severe in the girl. This report illustrates that siblings with the same genotype can respond very differently to rhGH, and it highlights the need for early endocrine, metabolic, and immunological surveillance in children with CHH.
Authors
- Maria Miguel Gomes (ORCID: https://orcid.org/0000-0002-1728-9387)
- Lara Torres
- Mariana Portela
- Ana Antunes
- Sofia Martins
Publication Details
- Journal
- Cureus
- Published
- 2026-11-21
- DOI
- https://doi.org/10.7759/cureus.120056
- Primary Topic
- Growth Hormone and Insulin-like Growth Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00